Dingdong (Cayman) Ltd
DDL NYSE Retail-Catalog & Mail-Order Houses Financials FY2019โFY2025
What Dingdong (Cayman) Ltd does
No business description yet.
- Legal name
- Dingdong (Cayman) Ltd
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 20-F ยท Apr 24, 2026
- Accession ยท CIK
- 0001193125-26-174971
0001854545
Revenue and margins
Dingdong (Cayman) Ltd had $3.4B of revenue in fiscal 2025, up 5.7% on the year before.
Net income and earnings per share
Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was $49.8M in fiscal 2025, 1.5% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Dingdong (Cayman) Ltd returned โ to shareholders in fiscal 2025. The diluted share count rose 0.0%.
Balance sheet
Cash, debt and the ratios that show how comfortably Dingdong (Cayman) Ltd can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $823M | $941M | $747M | $610M | $568M |
| Debt incl. finance leases | $500M | $614M | $464M | $220M | $124M |
| Net debt / EBITDA | โ | โ | โ80.5x | โ8.5x | โ13.9x |
| Debt / equity | 4.4x | 13.7x | 8.6x | 2.0x | 0.8x |
| Interest coverage | โ74.8x | โ6.0x | โ1.3x | 4.5x | 7.8x |
| Current ratio | 0.9x | 0.9x | 0.9x | 1.0x | 1.1x |
| Quick ratio | 0.8x | 0.8x | 0.9x | 0.9x | 0.9x |
| Total assets | $1.5B | $1.4B | $1.1B | $975M | $1.0B |
| Total liabilities | $1.4B | $1.3B | $1.0B | $849M | $834M |
| Shareholders' equity | $115M | $45.0M | $53.8M | $109M | $149M |
| Net debt (โ = net cash) | โ$323M | โ$327M | โ$283M | โ$390M | โ$444M |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. โPlanโ marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
โ
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8โ9 is strong, 0โ2 weak.
| Test | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|
| Net income is positive | โ | โ | โ | โ | โ | โ | โ |
| Cash from operations is positive | โ | โ | โ | โ | โ | โ | โ |
| Return on assets rose | โ | โ | โ | โ | โ | โ | โ |
| Cash from operations exceeds net income | โ | โ | โ | โ | โ | โ | โ |
| Debt fell relative to assets | โ | โ | โ | โ | โ | โ | โ |
| Current ratio rose | โ | โ | โ | โ | โ | โ | โ |
| Share count didn't rise | โ | โ | โ | โ | โ | โ | โ |
| Gross margin rose | โ | โ | โ | โ | โ | โ | โ |
| Revenue rose relative to assets | โ | โ | โ | โ | โ | โ | โ |
| F-score | โ / 3 | โ / 4 | 2 / 7 | 5 / 7 | 3 / 7 | 7 / 7 | 6 / 7 |
| Accruals ratio | โ | โ21.6% | โ10.6% | โ9.3% | 1.7% | โ8.4% | โ4.3% |
| Altman Z'' | โ | โ11.46 | โ9.38 | โ5.77 | โ6.15 | โ5.70 | โ5.58 |
7 years of figures
Amounts in USD. Hover a ratioโs name for its definition.
| Fiscal year | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|
| Income statement | |||||||
| Revenue | $562M | $1.6B | $3.1B | $3.6B | $2.8B | $3.2B | $3.4B |
| Operating income | โ$252M | โ$458M | โ$987M | โ$119M | โ$18.4M | $29.8M | $18.3M |
| Interest expense | $8.4M | $5.6M | $13.2M | $19.9M | $14.0M | $6.6M | $2.3M |
| Pretax income | โ$271M | โ$460M | โ$995M | โ$119M | โ$10.1M | $44.5M | $33.5M |
| Income tax | $0.0M | $0.0M | $1.5M | $1.0M | $2.7M | $2.2M | $1.3M |
| Net income | โ$271M | โ$460M | โ$997M | โ$120M | โ$12.9M | $42.3M | $32.2M |
| Net income to common | โ$289M | โ$507M | โ$1.0B | โ$121M | โ$14.1M | $41.0M | $30.8M |
| Diluted EPS | โ$14.09 | โ$23.87 | โ | โ | โ | โ | โ |
| Diluted shares | 0.02B | 0.02B | โ | โ | โ | โ | โ |
| Cash flow | |||||||
| Cash from operations | โ$140M | โ$298M | โ$879M | $13.0M | โ$33.1M | $129M | $74.5M |
| Capital expenditure | $18.1M | $36.0M | $70.0M | $18.8M | $11.8M | $13.6M | $24.7M |
| Free cash flow | โ$158M | โ$334M | โ$949M | โ$5.9M | โ$44.9M | $115M | $49.8M |
| Depreciation and amortization | $5.0M | $16.7M | $33.0M | $30.3M | $21.9M | $15.9M | $13.6M |
| Stock-based compensation | $0.3M | $22.2M | $48.9M | $35.0M | $19.3M | $16.5M | $10.9M |
| Balance sheet | |||||||
| Cash and short-term investments | $135M | $364M | $823M | $941M | $747M | $610M | $568M |
| Total debt | โ | $211M | $500M | $614M | $464M | $220M | $124M |
| Current assets | โ | $463M | $1.0B | $1.1B | $866M | $735M | $720M |
| Current liabilities | โ | $725M | $1.2B | $1.2B | $916M | $722M | $685M |
| Inventory | โ | $59.1M | $84.6M | $87.7M | $66.4M | $75.8M | $81.5M |
| Property and equipment, net | โ | $41.7M | $74.4M | $45.7M | $26.6M | $24.2M | $33.2M |
| Total assets | โ | $753M | $1.5B | $1.4B | $1.1B | $975M | $1.0B |
| Total liabilities | โ | $867M | $1.4B | $1.3B | $1.0B | $849M | $834M |
| Shareholders' equity | โ$358M | โ$905M | $115M | $45.0M | $53.8M | $109M | $149M |
| Margins | |||||||
| Operating margin | โ44.9% | โ27.9% | โ31.7% | โ3.3% | โ0.7% | 0.9% | 0.5% |
| EBITDA margin | โ44.0% | โ26.9% | โ30.6% | โ2.5% | 0.1% | 1.4% | 0.9% |
| Net margin | โ48.3% | โ28.0% | โ32.0% | โ3.3% | โ0.5% | 1.3% | 1.0% |
| FCF margin | โ28.1% | โ20.3% | โ30.4% | โ0.2% | โ1.6% | 3.6% | 1.5% |
| Returns | |||||||
| Return on capital employed | โ | โ1,614.3% | โ302.8% | โ70.0% | โ10.9% | 11.8% | 5.8% |
| Return on equity | โ | โ | โ | โ150.2% | โ26.1% | 51.8% | 25.0% |
| Return on assets | โ | โ61.1% | โ89.2% | โ8.4% | โ1.1% | 4.1% | 3.3% |
| Return on tangible equity | โ | โ | โ908.7% | โ269.0% | โ26.2% | 37.5% | 20.7% |
| Growth | |||||||
| Revenue growth | โ | 192.5% | 90.0% | 15.3% | โ21.6% | 13.7% | 5.7% |
| Net income growth | โ | โ | โ | โ | โ | โ | โ23.8% |
| FCF growth | โ | โ | โ | โ | โ | โ | โ56.9% |
| Share count change | โ | 3.7% | โ | โ | โ | โ | โ |
| Financial health | |||||||
| Net debt / EBITDA | โ | โ | โ | โ | โ80.5x | โ8.5x | โ13.9x |
| Debt / equity | โ | โ | 4.4x | 13.7x | 8.6x | 2.0x | 0.8x |
| Interest coverage | โ30.0x | โ81.5x | โ74.8x | โ6.0x | โ1.3x | 4.5x | 7.8x |
| Current ratio | โ | 0.6x | 0.9x | 0.9x | 0.9x | 1.0x | 1.1x |
| Quick ratio | โ | 0.6x | 0.8x | 0.8x | 0.9x | 0.9x | 0.9x |
| Capital allocation | |||||||
| Capex / revenue | 3.2% | 2.2% | 2.2% | 0.5% | 0.4% | 0.4% | 0.7% |
| Stock comp / revenue | 0.1% | 1.4% | 1.6% | 1.0% | 0.7% | 0.5% | 0.3% |
| Quality scores | |||||||
| Piotroski F-score | โ | โ | 2.0 | 5.0 | 3.0 | 7.0 | 6.0 |
| Altman Z'' | โ | โ11.5 | โ9.4 | โ5.8 | โ6.2 | โ5.7 | โ5.6 |
| Accruals ratio | โ | โ21.6% | โ10.6% | โ9.3% | 1.7% | โ8.4% | โ4.3% |
Source: SEC EDGAR XBRL filings (CIK 0001854545). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. Filed in CNY under US GAAP and converted to US$: income and cash-flow lines at each period's average exchange rate, balance-sheet lines at the period-end rate. Per-share figures are per US-listed share (1 ADS = 3 ordinary shares). For information only โ not investment advice. Check the original filings before relying on any figure.
